Jump to
Administrator Info
Name: Karen Fitz
Email: [email protected]
Mail: 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455
Summary
Clinically Dr. Premnath focuses on myeloid malignancies and a premalignant condition called clonal hematopoiesis of indeterminate potential. Having completed training in palliative care in addition to hematology/oncology, a main focus of his research has been supportive care for cancer patients as well as other aspects of cancer care like financial toxicity that matter most to patients and caregivers. He is actively involved in clinical research in the myeloid realm and has recently had a Phase 1 trial approved in MDS/AML. He looks forward to starting a clonal hematopoiesis focused clinic and a biobank as part of that effort.
Awards and Recognition Received
Conquer Cancer Merit Award - ASCO Annual Meeting 05/2023
Fellowship Research Award- UTSW Medical Center in 2022 & 2023
TxSCO Outstanding Fellows Abstract Award 10/2021
Professional Memberships and Affiliations
American Society of Hematology
American Society of Oncology
American association for cancer research
Clinical Title
Hematologist; Oncologist
Research Interests
MDS/AML
CHIP
Supportive care
Phase 1 trials
Clinical Interests
MDS
AML
CHIP
MPN
CML
Academic Interests
Translational research
Pallonc
Supportive care
Board Certifications:
Hematology
American Board of Internal Medicine, 2023
Oncology
American Board of Internal Medicine, 2023
Hospice and Palliative Medicine
American Board of Internal Medicine, 2022
Internal Medicine
American Board of Internal Medicine, 2021
Preferred Pronouns
He/Him